Do we need controlled clinical trials in pulmonary arterial hypertension? Galie N. Eur Respir J 2001; 17: 1-3 | |
Inflammation and infection in cystic fibrosis - hen or egg? Hoiby N. Eur Respir J 2001; 17: 4-5 | |
Trials of inhaled Iloprost and other new vasodilating prostaglandins Higenbottam T., Siddons T. Eur Respir J 2001; 17: 6-7 | |
Long-term treatment of pulmonary hypertension with aerosolized iloprost Machherndl S., Kneussl M., Baumgartner H., Schneider B., Petkov V., Schenk P., Lang I.M. Eur Respir J 2001; 17: 8-13 | |
Ultrasonic versus jet nebulization of iloprost in severe pulmonary hypertension Gessler T., Schmehl T., Hoeper M.M., Rose F., Ghofrani H.A., Olschewski H., Grimminger F., Seeger W. Eur Respir J 2001; 17: 14-19 | |
Role of NO pathway, calcium and potassium channels in the peripheral pulmonary vascular tone in dogs Chabot F., Schrijen F., Saunier C. Eur Respir J 2001; 17: 20-26 | |
Inflammation in cystic fibrosis airways: relationship to increased bacterial adherence Scheid P., Kempster L., Griesenbach U., Davies J.C., Dewar A., Weber P.P., Colledge W.H., Evans M.J., Geddes D.M., Alton E.W.F.W. Eur Respir J 2001; 17: 27-35 | |
Nebulized heparin in Burkholderia cepacia colonized adult cystic fibrosis patients Ledson M., Gallagher M., Hart C.A., Walshaw M. Eur Respir J 2001; 17: 36-38 | |
Nedocromil sodium versus sodium cromoglycate in treatment of exercise-induced bronchoconstriction: a systematic review Kelly K.D., Spooner C.H., Rowe B.H. Eur Respir J 2001; 17: 39-45 | |
Methacholine inhalation challenge: a shorter, cheaper and safe approach Izbicki G., Bar-Yishay E. Eur Respir J 2001; 17: 46-51 | |
Development and validation of the Adolescent Asthma Quality of Life Questionnaire (AAQOL) Rutishauser C., Sawyer S.M., Bond L., Coffey C., Bowes G. Eur Respir J 2001; 17: 52-58 | |
Genetic polymorphisms of CC chemokine receptor 3 in Japanese and British asthmatics Fukunaga K., Asano K., Mao X-Q., Gao P-S., Roberts M.H., Oguma T., Shiomi T., Kanazawa M., Adra C.N., Shirakawa T., Hopkin J.M., Yamaguchi K. Eur Respir J 2001; 17: 59-63 | |
Bronchoconstriction induced by inhaled adenosine 5'-monophosphate in subjects with allergic rhinitis Prieto L., Gutierrez V., Linana J., Marin J. Eur Respir J 2001; 17: 64-70 | |
Respiratory impedance response to continuous negative airway pressure in awake controls and OSAS Lorino A.M., Lofaso F., Dahan E., Harf A., Lorino H. Eur Respir J 2001; 17: 71-78 | |
Magnetic resonance imaging of the pharynx in OSA patients and healthy subjects Ciscar M.A., Juan G., Martinez V., Ramon M., Lloret T., Minguez J., Armengot M., Marin J., Basterra J. Eur Respir J 2001; 17: 79-86 | |
Reappraisal of the aetiology and prognostic factors of severe acute respiratory failure in HIV patients Alves C., Nicolas J.M., Miro J.M., Torres A., Agusti C., Gonzalez J., Rano A., Benito N., Moreno A., Garcia F., Milla J., Gatell J.M. Eur Respir J 2001; 17: 87-93 | |
Plethysmography for the assessment of pneumococcal pneumonia and passive immunotherapy in a mouse model de Hennezel L., Debarre S., Ramisse F., Delamanche S., Harf A., Alonso J-M., Calvet J-H. Eur Respir J 2001; 17: 94-99 | |
In vitro assessment of equipment and software to assess tidal breathing parameters in infants Schmalisch G., Foitzik B., Wauer R.R., Stocks J. Eur Respir J 2001; 17: 100-107 | |
Effect of apparatus dead space on breathing parameters in newborns: "flow-through" versus conventional techniques Schmalisch G., Foitzik B., Wauer R.R., Stocks J. Eur Respir J 2001; 17: 108-114 | |
Dynamic respiratory system mechanics in infants during pressure and volume controlled ventilation Kessler V., Guttmann J., Newth C.J.L. Eur Respir J 2001; 17: 115-121 | |
Smoking-related interstitial lung diseases: a concise review Ryu J.H., Colby T.V., Hartman T.E., Vassallo R. Eur Respir J 2001; 17: 122-132 | |
Fungal infections in transplant recipients Nicod L.P., Pache J-C., Howarth N. Eur Respir J 2001; 17: 133-140 | |
Passive respiratory mechanics: the occlusion techniques Gappa M., Colin A.A., Goetz I., Stocks J. Eur Respir J 2001; 17: 141-148 | |
Yellow nail syndrome: does protein leakage play a role? D'Alessandro A., Muzi G., Monaco A., Filiberto S., Barboni A., Abbritti G. Eur Respir J 2001; 17: 149-152 | |
Sleep apnoea and Turner's syndrome Orliaguet O., Pepin J.L., Bettega G., Ferretti G., Mignotte H.N., Levy P. Eur Respir J 2001; 17: 153-155 | |
Allergic bronchopulmonary aspergillosis in cystic fibrosis Kastelik J.A., Aziz I., Redington A.E., Morice A.H. Eur Respir J 2001; 17: 156 | |
Systemic bioavailability of inhaled steroids: the importance of appropriate and comparable methodology Derendorf H., Daley-Yates P.T., Pierre L.N., Efthimiou J. Eur Respir J 2001; 17: 157-158 | |